Law360, New York (November 04, 2009) -- Kaiser Foundation Health Plan Inc. is appealing a judgment in favor of Abbott Laboratories in a patent and antitrust dispute involving multidistrict litigation over the hypertension drug Hytrin.
The health plan filed notice on Tuesday it would appeal the decision by a U.S. District Court for the Central District of California to the U.S. Court of Appeals for...
